These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 9637744

  • 1. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J, Gravenstein S, Briggs D, Miller B, Froeschle J, Dukes C, Le Mener V, Lutsch C.
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J, Cetre JC, Picot N, Lanta M, Briantais P, Vital S, Le Mener V, Lutsch C, Rotivel Y.
    Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine.
    Lang J, Attanath P, Quiambao B, Singhasivanon V, Chanthavanich P, Montalban C, Lutsch C, Pepin-Covatta S, Le Mener V, Miranda M, Sabchareon A.
    Acta Trop; 1998 Jul 30; 70(3):317-33. PubMed ID: 9777717
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].
    Hacibektaşoğlu A, Inal A, Eyigün C, Barut A, Türkay FA.
    Mikrobiyol Bul; 1992 Jan 30; 26(1):26-36. PubMed ID: 1574019
    [Abstract] [Full Text] [Related]

  • 5. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.
    Bakker AB, Python C, Kissling CJ, Pandya P, Marissen WE, Brink MF, Lagerwerf F, Worst S, van Corven E, Kostense S, Hartmann K, Weverling GJ, Uytdehaag F, Herzog C, Briggs DJ, Rupprecht CE, Grimaldi R, Goudsmit J.
    Vaccine; 2008 Nov 05; 26(47):5922-7. PubMed ID: 18804136
    [Abstract] [Full Text] [Related]

  • 6. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D, Lalosević V, Lazarević-Ivanc Lj, Knezević I.
    Dev Biol (Basel); 2008 Nov 05; 131():421-9. PubMed ID: 18634504
    [Abstract] [Full Text] [Related]

  • 7. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK, Londhe VA, Akarte S, Briggs D.
    J Assoc Physicians India; 2003 Jul 05; 51():655-8. PubMed ID: 14621031
    [Abstract] [Full Text] [Related]

  • 8. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C.
    Vaccine; 2006 May 08; 24(19):4116-21. PubMed ID: 16545510
    [Abstract] [Full Text] [Related]

  • 9. Antibody responses to human diploid cell vaccine for rabies with and without human rabies immune globulin.
    Mertz GJ, Nelson KE, Vithayasai V, Makornkawkeyoon S, Rosanoff EI, Tint H, Wiktor TJ.
    J Infect Dis; 1982 May 08; 145(5):720-7. PubMed ID: 7077095
    [Abstract] [Full Text] [Related]

  • 10. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.
    Lang J, Simanjuntak GH, Soerjosembodo S, Koesharyono C.
    Bull World Health Organ; 1998 May 08; 76(5):491-5. PubMed ID: 9868840
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine.
    Arora A, Moeller L, Froeschle J.
    J Travel Med; 2004 May 08; 11(4):195-9. PubMed ID: 15541220
    [Abstract] [Full Text] [Related]

  • 12. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M, Partridge R, Jay GD, Rozzoli DE, Pandey P.
    J Travel Med; 2006 May 08; 13(6):329-33. PubMed ID: 17107424
    [Abstract] [Full Text] [Related]

  • 13. Studies with human diploid cell strain rabies vaccine and human antirabies immunoglobulin in man.
    Nicholson KG, Turner GS.
    Dev Biol Stand; 1978 May 08; 40():115-20. PubMed ID: 680384
    [Abstract] [Full Text] [Related]

  • 14. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule].
    Landry P, Lazzaro M, Darioli R.
    Praxis (Bern 1994); 1998 Sep 09; 87(37):1177-9. PubMed ID: 9785997
    [Abstract] [Full Text] [Related]

  • 15. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.
    Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, Sun B, Hull HF, Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2008 May 23; 57(RR-3):1-28. PubMed ID: 18496505
    [Abstract] [Full Text] [Related]

  • 16. Intradermal pre-exposure rabies immunisation in New Zealand.
    Shaw MM, Leggat PA, Williams ML.
    Travel Med Infect Dis; 2006 Jan 23; 4(1):29-33. PubMed ID: 16887722
    [Abstract] [Full Text] [Related]

  • 17. Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects.
    Aoki FY, Rubin ME, Friesen AD, Bowman JM, Saunders JR.
    J Biol Stand; 1989 Jan 23; 17(1):91-104. PubMed ID: 2646301
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines.
    Quiambao BP, Lang J, Vital S, Montalban CG, Le Mener V, Wood SC, Miranda E.
    Acta Trop; 2000 Feb 25; 75(1):39-52. PubMed ID: 10708006
    [Abstract] [Full Text] [Related]

  • 19. An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment.
    Ubol S, Phanuphak P.
    Clin Exp Immunol; 1986 Mar 25; 63(3):491-7. PubMed ID: 3708902
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity and safety of purified Vero-cell rabies vaccine in severely rabies-exposed patients in China.
    Wang XJ, Lang J, Tao XR, Shu JD, Le Mener V, Wood SC, Huang JT, Zhao SL.
    Southeast Asian J Trop Med Public Health; 2000 Jun 25; 31(2):287-94. PubMed ID: 11127328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.